Fluorinated BPA derivatives enhanced <sup>10</sup>B delivery in tumors-Reference-Cited by-同舟云学术

Fluorinated BPA derivatives enhanced ¹⁰B delivery in tumors

Published:2024 Issue:25 Volume:12 Page:6128-6136
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Ding Dandan¹²,Mo Shushan¹³,Li Qishan¹⁴,Wang Fei¹²,Wang Xueyi¹²,Ou Caiwen¹,Li Zhenhua¹²^ORCID

Affiliation:

1. The Tenth Affiliated Hospital, Southern Medical University (Dongguan People's Hospital), Dongguan 523059, China

2. Guangdong Provincial Key Laboratory of Cardiac Function and Microcirculation, Guangdong 510515, China

3. College of Pharmaceutical Science, Key Laboratory of Pharmaceutical Quality Control of Hebei Province, Hebei University, Baoding 071002, China

4. The First School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong 510515, China

Abstract

Fluorinated BPA derivatives exhibited improved 10B accumulation in tumors, and enhanced T/B and T/N ratios compared to clinical boron drug fructose-BPA (f-BPA).

Funder

National Natural Science Foundation of China

China Postdoctoral Science Foundation

Basic and Applied Basic Research Foundation of Guangdong Province

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/TB/D4TB00846D

Reference34 articles.

1. Boron Neutron Capture Therapy of Cancer: Current Status and Future Prospects

2. Boron Neutron Capture Therapy for Cancer

3. Boron neutron capture therapy: Current status and future perspectives

4. Localized nuclear reaction breaks boron drug capsules loaded with immune adjuvants for cancer immunotherapy

5. Critical review, with an optimistic outlook, on Boron Neutron Capture Therapy (BNCT)